Psychotherapy for Psychosis, Adverse Events, and Substance Misuse

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

September 15, 2023

Study Completion Date

September 30, 2023

Conditions
Psychotic DisordersStress Disorders, TraumaticSubstance Use
Interventions
BEHAVIORAL

Prolonged exposure (PE)+ therapy

The intervention will be adapted prolonged exposure therapy, called PE+ therapy. Participants will receive 15 weekly 90-minute sessions of PE+; these appointments will be divided into five sets of three sessions each: 1) psychoeducation about AEs, SM, and the interplay of both with psychosis; 2) emotion regulation strategies; 3) imaginal exposures, 4) in vivo exposures, and 5) review of treatment and planning for termination and maintenance.

OTHER

Treatment as usual (TAU)

The intervention will be antipsychotics prescribed by clinicians working within the Nova Scotia Early Psychosis Program (NSEPP) as well as case management supplied by their primary nurse. Program participants will have access to educational programs about psychosis, skills/vocational training, as well as familial education and support.

Trial Locations (1)

B3H 2E2

Nova Scotia Early Psychosis Program (NSEPP), Abbie J. Lane Memorial Building, Halifax

All Listed Sponsors
collaborator

Queen Elizabeth II Health Sciences Centre Foundation

UNKNOWN

collaborator

Research Nova Scotia

UNKNOWN

collaborator

Killam Laureates

UNKNOWN

lead

Nova Scotia Health Authority

OTHER

NCT04546178 - Psychotherapy for Psychosis, Adverse Events, and Substance Misuse | Biotech Hunter | Biotech Hunter